Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
about
Osteoimmunology: interactions of the bone and immune systemOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsInterleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus.Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: a novel mechanism mediating its blockade of osteoclastogenesisFTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2).Essential role of DAP12 signaling in macrophage programming into a fusion-competent state.Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean populationOsteoimmunology: cytokines and the skeletal system.Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directlyOsteoimmunology in orthodontic tooth movement.Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264.Proteomic approaches to study osteoclast biology.Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4.
P2860
Q24655113-903AAE92-6493-4174-8FED-A4EC8A870F98Q26828486-EB2482BC-ED74-4639-B224-987A1A5C226DQ33269870-60A5919D-C047-4F8C-B450-7648EA880BE7Q34700316-8CB5BD33-0D05-4658-9A74-CF7D006D200EQ35863762-C67B0A28-57D4-488B-AA21-DC54EFEC4BCBQ36632162-2E5DDFDE-A484-4929-9A96-A33691DE2580Q37047010-7DE73254-F957-4748-BD11-B59CB792FB41Q37171072-D98C4964-1B14-41FC-9DD0-9EB6CE14396AQ37184862-8018DDCC-3F6F-4602-B55E-E317794B833CQ37235713-0A953E5C-6428-45B2-A0A6-A04506252558Q37432210-BDDB08EB-2BF5-4CE7-8C63-9F10D8E3BEB2Q38231572-08C0FDD6-FFC5-428C-8AA4-CEB0229CB52FQ38821814-30A7C480-2E19-43E0-A6FD-EB4D4BE51574Q38878942-59C2EEA7-DC58-4F9B-9D6A-E392D69B9706Q42272646-7B34A571-D8E5-4253-A692-6B9BC662DA89
P2860
Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interleukin-4 inhibits RANKL-i ...... ulation of osteoclastogenesis.
@en
type
label
Interleukin-4 inhibits RANKL-i ...... ulation of osteoclastogenesis.
@en
prefLabel
Interleukin-4 inhibits RANKL-i ...... ulation of osteoclastogenesis.
@en
P2093
P1476
Interleukin-4 inhibits RANKL-i ...... ulation of osteoclastogenesis.
@en
P2093
Eiji Sugiyama
Hirofumi Taki
Hiroyuki Hounoki
Kouichiro Shinoda
Masashi Kobayashi
Muneharu Maruyama
Saad Gad Kamel Mohamed
Tatsuro Miyahara
P304
P356
10.1016/J.BBRC.2005.02.049
P577
2005-04-01T00:00:00Z